MY179293A - Antifungal composition derived from clitoria ternatea flavonoid - Google Patents

Antifungal composition derived from clitoria ternatea flavonoid

Info

Publication number
MY179293A
MY179293A MYPI2016703260A MYPI2016703260A MY179293A MY 179293 A MY179293 A MY 179293A MY PI2016703260 A MYPI2016703260 A MY PI2016703260A MY PI2016703260 A MYPI2016703260 A MY PI2016703260A MY 179293 A MY179293 A MY 179293A
Authority
MY
Malaysia
Prior art keywords
flavonoid
composition
composition derived
clitoria ternatea
antifungal composition
Prior art date
Application number
MYPI2016703260A
Inventor
Mahsufi Mansor Sharif
Ramanathan Surash
Murugaiah Vickneswaran
Linggam Kamilla
Original Assignee
Univ Sains Malaysia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Sains Malaysia filed Critical Univ Sains Malaysia
Priority to MYPI2016703260A priority Critical patent/MY179293A/en
Priority to PCT/MY2017/050047 priority patent/WO2018048296A1/en
Publication of MY179293A publication Critical patent/MY179293A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)

Abstract

The present invention relates to an antifungal composition derived from Clitoria ternatea flavonoid. More particularly, the present invention relates to a flavonoid composition for use as an antifungal agent, characterized in that, the composition comprising kaempferol-3-O-? rhamnopyranosyl-(1-2)-?glucopyranoside, method of manufacturing and method of use thereof. The present invention provides a novel approach for development of a flavonoid composition comprising kaempferol-3-O-?-rhamnopyranosyl-(1-2)-?-glucopyranoside that can be combined with other drugs to form a synergistic drug combination that is capable of inhibiting fungal growth at low concentration effectively.
MYPI2016703260A 2016-09-07 2016-09-07 Antifungal composition derived from clitoria ternatea flavonoid MY179293A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
MYPI2016703260A MY179293A (en) 2016-09-07 2016-09-07 Antifungal composition derived from clitoria ternatea flavonoid
PCT/MY2017/050047 WO2018048296A1 (en) 2016-09-07 2017-08-11 Antifungal composition derived from clitoria ternatea flavonoid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MYPI2016703260A MY179293A (en) 2016-09-07 2016-09-07 Antifungal composition derived from clitoria ternatea flavonoid

Publications (1)

Publication Number Publication Date
MY179293A true MY179293A (en) 2020-11-03

Family

ID=61562821

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2016703260A MY179293A (en) 2016-09-07 2016-09-07 Antifungal composition derived from clitoria ternatea flavonoid

Country Status (2)

Country Link
MY (1) MY179293A (en)
WO (1) WO2018048296A1 (en)

Also Published As

Publication number Publication date
WO2018048296A1 (en) 2018-03-15

Similar Documents

Publication Publication Date Title
PH12015502310A1 (en) Pharmaceutical composition, methods for treating and uses thereof
DOP2017000137A (en) BENZAMIDES SUBSTITUTED WITH 1,3-THIAZOL-2-ILO.
MX2019001125A (en) Macrocycle kinase inhibitors.
MX2022013612A (en) Combinations of lsd1 inhibitors for the treatment of hematological malignancies.
WO2017100063A3 (en) Stable ready-to-drink beverage compositions comprising lipophilic active agents
NZ712270A (en) Pharmaceutical composition of s-ketamine hydrochloride
WO2015023976A3 (en) Selective grp94 inhibitors and uses thereof
MX361278B (en) Inhibiting or reducing fungal growth.
WO2015058664A8 (en) Use of icaritin in preparing medicament for preventing or treating hematocytopenia
MX2020002123A (en) Ribociclib salts and solid state forms thereof.
PH12016502544B1 (en) Pharmaceutical preparation containing entecavir as active ingredient, and preparation method therefor
EP3295946A4 (en) Composition, containing lithospermi radix extract as active ingredient, for preventing, alleviating, or treating peripheral neuropathy
PH12017502081A1 (en) Composition, containing quisqualis indica extract, for preventing or treating prostatic hyperplasia
IL268224A (en) Pharmaceutical composition for preventing and treating pancreatic cancer, containing gossypol and phenformin as active ingredients
WO2014130313A3 (en) Methods and compositions relating to the treatment of cancer
MX354514B (en) Coffee extract containing protocatechuic acid and its agrochemical use against plant pathogens.
MX2015017446A (en) New macrocyclic amidinourea derivatives, methods of preparation and uses thereof as chitinase inhibitors.
WO2014133811A3 (en) Compounds from invasive salvinias and methods of using the same
EP3006434A4 (en) Novel compound derived from plant of genus quamoclit and composition containing same as active ingredient for preventing or treating diabetes
PH12019502145A1 (en) Agent for preventing myopia, treating myopia, and/or preventing myopia progression comprising tiotropium as active ingredient
EP3398608A4 (en) Pharmaceutical composition for preventing and treating cancer or cancer metastasis, containing pstl1 protein as active ingredient
EP3284464A4 (en) Composition for preventing and treating pancreatitis containing naphthoquinone-based compound as active ingredient
EP3610866A4 (en) Pharmaceutical composition for preventing and treating cancer, containing malate-aspartate shuttle inhibitor and anticancer drug as active ingredients
MY179293A (en) Antifungal composition derived from clitoria ternatea flavonoid
MX356102B (en) Compounds and methods for treating leukemia.